Wilson / SPECIAL/SUBGROUP / EXECUTIVE SUMMARY Warner Chilcott LLC / Warner Chilcott LLC / ITT / /
Event
FDA Phase / Product Recall / Product Issues / /
IndustryTerm
study protocol / healthcare providers / /
MedicalCondition
C. trachomatis infection / genital chlamydial infections / primary deficiency / persistent Chlamydia infection / uncomplicated urogenital C. trachomatis infection / Uncomplicated Urogenital Chlamydia trachomatis Infection / infection / untreated infection / MS / C. trachomatis infections / /
Organization
U.S. Department of Health and Human Services / Translational Sciences Office / FDA / Biometrics Division / Food and Drug Administration Center for Drug Evaluation / Research Office / Medical Division / Division of Anti-infective Products / /
Person
Carmen Debellas / John Alexander / Daphne Lin / Dmitri Iarikov / Concurring Reviewers / Meg Gamalo / Lillian Patrician / Thamban Valappil / Edward Cox / /
Position
Director of OAP / Project Manager / Statistical Team Leader / /